Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications ; day:30 ; month:5 ; year:2020 ; pages:1-25
Heart failure reviews ; (30.5.2020), 1-25
- Creator
-
Sobczuk, Paweł
Czerwińska, Magdalena
Kleibert, Marcin
Cudnoch-Jędrzejewska, Agnieszka
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10741-020-09977-1
- URN
-
urn:nbn:de:101:1-2020080219054180353036
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sobczuk, Paweł
- Czerwińska, Magdalena
- Kleibert, Marcin
- Cudnoch-Jędrzejewska, Agnieszka
- SpringerLink (Online service)
Other Objects (12)
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Anthracycline Chemotherapy and Cardiotoxicity
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Anthracycline Chemotherapy and Cardiotoxicity
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Anthracycline Chemotherapy and Cardiotoxicity
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II